Patents by Inventor Pradeep Aggarwal

Pradeep Aggarwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antioxidant free, norepinephrine bitartrate injection in amber glass vials
    Patent number: 11331266
    Abstract: The application provides pharmaceutical compositions comprising stable concentrated solutions of antioxidant free norepinephrine bitartrate for injection dispensed in glass containers and methods of providing such solutions to a subject.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: May 17, 2022
    Assignee: Medefil, Inc.
    Inventors: Pradeep Aggarwal, Lincoln W. Maina, Sunil Potdar, Ravinder Malhotra, Venugopal Chenna, Sandeep Pallerla, NagaBhuvan Kumar Nandipati
  • Dexmedetomidine injection premix formulation in ready to use (RTU) bags
    Patent number: 11160791
    Abstract: The application provides pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof and sodium chloride, wherein the composition is disposed within a plastic container as a ready to use premixture. The application also provides a premixed, ready to use sterile dexmedetomidine solution comprising dexmedetomidine and sodium chloride, wherein the solution is provided within a plastic container. Also provided are methods of providing dexmedetomidine to a subject in need of such, wherein the composition is disposed within a sealed plastic container.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: November 2, 2021
    Assignee: Medefil, Inc.
    Inventors: Lakshmi Prasanna Kolluru, Zhiwen Guan, Sunil Potdar, Ravinder Malhotra, Pradeep Aggarwal
  • DEXMEDETOMIDINE INJECTION PREMIX FORMULATION IN READY TO USE (RTU) BAGS
    Publication number: 20200138788
    Abstract: The application provides pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof and sodium chloride, wherein the composition is disposed within a plastic container as a ready to use premixture. The application also provides a premixed, ready to use sterile dexmedetomidine solution comprising dexmedetomidine and sodium chloride, wherein the solution is provided within a plastic container. Also provided are methods of providing dexmedetomidine to a subject in need of such, wherein the composition is disposed within a sealed plastic container.
    Type: Application
    Filed: October 30, 2019
    Publication date: May 7, 2020
    Applicant: Medefil, Inc.
    Inventors: Lakshmi Prasanna Kolluru, Zhiwen Guan, Sunil Potdar, Ravinder Malhotra, Pradeep Aggarwal